CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	55.43B
Revenue (ttm)	1.93B
Net Income (ttm)	-52.24M
Shares Out	1.39B
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	66.51
Dividend	0.02 (0.05%)
Ex-Dividend Date	Apr 25, 2024

Volume	6,848,796
Average Volume	12,964,778
Open	38.93
Previous Close	39.80
Day's Range	38.93 - 41.19
52-Week Range	21.07 - 48.45
Beta	0.28
RSI	49.11
Earnings Date	Apr 24, 2025

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, Ch...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.